ResMed, a maker of sleep and respiratory medical equipment, has introduced the Narval CC, a mandibular repositioning device that offers an alternative solution to patients for snoring and obstructive sleep apnea, to the U.S. market.
ResMed's introduction of Narval CC follows its acquisition of Labaratoires Narval. With the acquisition, ResMed added an additional therapy method to complement its line of comprehensive positive airway pressure (CPAP) products. With the release of Narval CC, ResMed is now the only PAP company with a customized solution for noncompliant patients or patients who refuse PAP treatment, according to Michael Farrell, president of ResMed Americas.
The custom-made Narval CC maintains the lower jaw in a forward position with a patented optimized retention of the mandible. This allows natural movement of the jaw, increasing patient comfort, and resulting in superior compliance and efficacy, according to the company.
